Medical News

RSS

The Lipitor story: Drug companies brace for losses as patents expire on this and other popular medications

News outlets analyze the impact that generic Lipitor could have on costs and the "era of 'blockbuster drugs'" as well as the strategies from Lipitor's maker to block its generic competitors. Meanwhile, some of these generics are already reaching the marketplace.

2 Dec 2011

Novelos prices underwritten public offering of $5,904,000 of common stock

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced the pricing of an underwritten public offering of 9,840,000 units at $0.60 per unit for gross proceeds of $5,904,000.

2 Dec 2011

Arbor files first NDA with U.S. FDA

Arbor Pharmaceuticals announced today that it has filed its first New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The recently filed product has been granted an Orphan designation by the FDA which provides seven years of market exclusivity.

2 Dec 2011

Health disparity tends to increase among young U.S. adults

Levels of health disparity have increased substantially for people born in the United States after 1980, according to new research.

2 Dec 2011

Low-carbohydrate diet may help prepubescent girls avoid obesity associated risks

A low-carbohydrate diet may help prepubescent girls avoid some risks associated with obesity, such as diabetes and heart disease, according to research from the University of Alabama at Birmingham.

2 Dec 2011

HIV physicians launch CALIBER of Care initiative

Today, on World AIDS Day, an expert panel of physicians from HIV clinics across the country announced the launch of the CALIBER (Clinic Activation to Lead and Implement Best practices for Enhancing Response to HIV) of Care© initiative, a partnership with Merck that is designed to help improve HIV patient care through physician-patient communication resources.

2 Dec 2011

Two studies uncover limitations in screening for hepatocellular carcinoma

Two studies available in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, have uncovered limitations in screening for primary liver cancer, also known as hepatocellular carcinoma.

2 Dec 2011

Cheaper test as effective as a more sophisticated test in guiding anti-retroviral drug treatment

A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found - a discovery that could be particularly important in rural Africa.

2 Dec 2011

State roundup: Florida's growing Medicaid costs; Missouri insurance rates; Maryland's unspent disabilities money

Florida Governor Rick Scott said he has whittled down a corporate tax-relief plan compared with what he sought last year because of a ballooning deficit driven by health-care spending. "Medicaid is growing way faster than we thought," the former hospital executive said yesterday. ... Florida, which closed a $3.8 billion budget gap for fiscal 2012, is facing another of as much as $2.3 billion next year.

2 Dec 2011

Mylan confirms generic Generess Fe patent challenge

Mylan Inc. today confirmed that it and Famy Care Ltd. have been sued by Warner Chilcott Company LLP, in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Norethindrone and Ethinyl Estradiol Chewable Tablets, 0.8 mg/0.025 mg and Ferrous Fumarate Chewable Tablets. This product is the generic version of Generess Fe, a 28-day regimen indicated for use by women to prevent pregnancy.

2 Dec 2011

Radioimmunotherapy shows promise against fungal diseases

Invasive fungal infections (IFI) are a major threat to individuals with cancer, transplants, HIV, and other conditions that weaken their immune system. New research has shown that radioimmunotherapy (RIT) could be a promising avenue for development of new types of treatment of fungal diseases, according to a paper published by scientists of the Joint Research Centre (JRC) in collaboration with other researchers.

2 Dec 2011

Idera receives FDA notification to proceed with IMO-3100 Phase 2 clinical trial for psoriasis

Idera Pharmaceuticals, Inc. today announced the receipt of verbal notification from the Food and Drug Administration that the company may proceed with a Phase 2 clinical trial of IMO-3100 in patients with psoriasis based on a trial protocol submitted by the company in October 2011.

2 Dec 2011

AVEO, Boehringer Ingelheim enter development and manufacturing agreement for ficlatuzumab

AVEO Pharmaceuticals, Inc. and Boehringer Ingelheim today announced that they have entered into an agreement for large-scale process development and clinical manufacturing of ficlatuzumab, AVEO's novel HGF inhibitory antibody that is currently in Phase 2 clinical development in patients with non-small cell lung cancer.

2 Dec 2011

EGCG may prevent HCV reinfection after liver transplantation

German researchers have determined that epigallocatechin-3-gallate (EGCG)—a flavonoid found in green tea—inhibits the hepatitis C virus (HCV) from entering liver cells.

1 Dec 2011

ADVENTRX, FDA discuss ANX-188 development plans for treatment of sickle cell crisis

ADVENTRX Pharmaceuticals, Inc. announced today that it met with the U.S. Food and Drug Administration (FDA) to review development plans for ANX-188 (purified poloxamer 188), the Company's first-in-class treatment for sickle cell patients experiencing vaso-occlusive crisis.

1 Dec 2011

Positive interim data from Anthera's PEARL-SC phase 2b clinical study in systemic lupus erythematosus

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced positive interim biomarker data from the PEARL-SC phase 2b clinical study in patients with systemic lupus erythematosus.

1 Dec 2011

Body's surveillance for cancer causing damage and response to allergies share common pathway

CANCER RESEARCH UK scientists have found that the body's surveillance for cancer causing damage and its response to allergies share a common pathway, according to research published in Science on Thursday.

1 Dec 2011

Republicans advance plan to charge wealthy beneficiaries more for Medicare to offset cost of payroll tax extension

The proposal would require people who earn more than $1 million to pay the full cost of Medicare. Meanwhile, House Majority Leader Eric Cantor, R-Va., is floating a "trigger bargain" that would delay for one year the automatic spending cuts scheduled to begin in 2013 and also could include a payroll tax extension and a fix for physician's Medicare payment rate.

1 Dec 2011

Insights into causes of Idiopathic Pulmonary Fibrosis

Tracking individual cells within the lung as they move around and multiply has given Duke University researchers new insights into the causes of Idiopathic Pulmonary Fibrosis (IPF) a disease which can only be treated now by lung transplantation.

1 Dec 2011

Enrollment complete in Ceregene's CERE-120 Phase 2b trial for Parkinson's

Ceregene, Inc. reported today that it has completed enrollment in its Phase 2b trial of CERE-120, a gene therapy product expressing the neurturin (NRTN) gene for the treatment of Parkinson's disease.

1 Dec 2011

Medical News

The Lipitor story: Drug companies brace for losses as patents expire on this and other popular medications

Novelos prices underwritten public offering of $5,904,000 of common stock

Arbor files first NDA with U.S. FDA

Health disparity tends to increase among young U.S. adults

Low-carbohydrate diet may help prepubescent girls avoid obesity associated risks

HIV physicians launch CALIBER of Care initiative

Two studies uncover limitations in screening for hepatocellular carcinoma

Cheaper test as effective as a more sophisticated test in guiding anti-retroviral drug treatment

State roundup: Florida's growing Medicaid costs; Missouri insurance rates; Maryland's unspent disabilities money

Mylan confirms generic Generess Fe patent challenge

Radioimmunotherapy shows promise against fungal diseases

Idera receives FDA notification to proceed with IMO-3100 Phase 2 clinical trial for psoriasis

AVEO, Boehringer Ingelheim enter development and manufacturing agreement for ficlatuzumab

EGCG may prevent HCV reinfection after liver transplantation

ADVENTRX, FDA discuss ANX-188 development plans for treatment of sickle cell crisis

Positive interim data from Anthera's PEARL-SC phase 2b clinical study in systemic lupus erythematosus

Body's surveillance for cancer causing damage and response to allergies share common pathway

Republicans advance plan to charge wealthy beneficiaries more for Medicare to offset cost of payroll tax extension

Insights into causes of Idiopathic Pulmonary Fibrosis

Enrollment complete in Ceregene's CERE-120 Phase 2b trial for Parkinson's

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News